000 | 01126 a2200325 4500 | ||
---|---|---|---|
005 | 20250517233753.0 | ||
264 | 0 | _c20190930 | |
008 | 201909s 0 0 eng d | ||
022 | _a2168-6084 | ||
024 | 7 |
_a10.1001/jamadermatol.2018.2526 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKaye, Alex | |
245 | 0 | 0 |
_aDupilumab for the Treatment of Recalcitrant Bullous Pemphigoid. _h[electronic resource] |
260 |
_bJAMA dermatology _c10 2018 |
||
300 |
_a1225-1226 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Letter | ||
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
650 | 0 | 4 |
_aDermatologic Agents _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aPemphigoid, Bullous _xdrug therapy |
700 | 1 | _aGordon, Samantha C | |
700 | 1 | _aDeverapalli, Sandhya C | |
700 | 1 | _aHer, Min Ji | |
700 | 1 | _aRosmarin, David | |
773 | 0 |
_tJAMA dermatology _gvol. 154 _gno. 10 _gp. 1225-1226 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1001/jamadermatol.2018.2526 _zAvailable from publisher's website |
999 |
_c28762353 _d28762353 |